Honored to be mentioned to Business Insider's 2024 "44 Startups to Bet Your Career On" list! 🧨 Alfie Health's precision approach to obesity management helps providers shift through the noise and provide high-quality, clinical-grade obesity management to patients... ...and it's not just conceptual. In partnership with a Richmond-based cardiology group, we demonstrated 7.7% average weight loss in the first 10 weeks. Reach out today to learn how your healthcare organization can partner with Alfie to deliver effective obesity management! #startup #obesity #glp1
Alfie Health
Hospitals and Health Care
New York, New York 1,428 followers
Your partner in AI-powered virtual obesity management.
About us
Acquired by knownwell - June 2024. Alfie Health is a virtual obesity management clinic, which uses its proprietary AI clinical decision support technology, ObesityRx™️, to recommend a combination of precision medicine and behavioral change to help patients sustainably lose weight.
- Website
-
https://www.joinalfie.com
External link for Alfie Health
- Industry
- Hospitals and Health Care
- Company size
- 2-10 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Weight loss, Digital Health, and Precision care
Locations
-
Primary
New York, New York, US
Employees at Alfie Health
Updates
-
Partnering with Metriport helps us deliver the highest quality clinical care for patients. Read the case study to learn more!
We're very excited to share our new case study with Alfie Health! 🎯 Alfie is a virtual obesity management clinic which uses AI clinical decision support technology to help patients sustainably lose weight. Through Metriport, Alfie unlocks full clinical histories for their patients in seconds. This enables them to identify crucial information, such as what medications a patient is currently taking, to help inform treatment decisions. "One of the best about getting started with Metriport was that they offered a no-code dashboard, enabling us to get instant access to full patient clinical histories with no engineering effort required." Learn more about how Alfie leverages Metriport to enhance patient care and advance their mission to reduce the impact of obesity on the American healthcare ecosystem: https://lnkd.in/gyx5r7vn #partnership #casestudy #clinicaldata #hie #ehr #patientcare #yc #obesitytreatment #api #metriport #alfie
How Alfie leverages Metriport data to power precision weight loss treatment | Case Study
metriport.com
-
Happy National NP Week! At Alfie Health, we are immensely proud and grateful for the dedicated Nurse Practitioners who are at the heart of our care teams. Every day, they go above and beyond to provide compassionate care and unparalleled support to our patients. These providers are the reason behind positive patient experiences: "My provider is great. She really goes above and beyond." "Your program and team have been life changers for me. I haven't felt this good in years." "I love meeting with my provider. They always provide insightful feedback into how I'm doing." Their expertise, empathy, and unwavering commitment to patient health are what makes our mission at Alfie Health possible. This week, we celebrate you, our NPs, for the stars that you are — not just during this week, but every single day. Thank you for your hard work, your resilience, and for the profound impact you make on the lives of those struggling with obesity. Learn more about our care team at https://lnkd.in/e3XTdfyQ #NPWeek #HealthcareHeroes #AlfieHealthAppreciates #obesity
-
-
"The idea that we're going to put 110 million Americans on a GLP-1 for $1,000 a month is a problem". Obesity medicine should comprise holistic, multi-modal care for patients, inclusive of behavioral guidance, mental health, surgery, and anti-obesity medications, not simply AOMs alone. Reach out today if you're looking for a holistic solution to help manage your patients with obesity!
Doctors grapple with patients' demand for weight-loss drugs
axios.com
-
As companies like Hennepin Healthcare, The University of Texas System, and Ascension drop coverage for GLP-1s, employees are left frustrated with existing options. Alfie offers a cost-effective, AI-powered virtual obesity solution that can help manage obesity in your patient population. With proven outcomes, our multi-modal approach determines how to use the right medications at the right time, in combination with intensive lifestyle change. Reach out today to partner with us! Read more about employers dropping weight loss coverage in the comments.
-
-
This Friday (10/13), Alexander Singh will be joining the Medical Society of Virginia (MSV) Annual Meeting. If you're in town, make sure to reach out!
If you're in Virginia this weekend for the Medical Society of Virginia (MSV) Annual Meeting, be sure to find me at the Lighthouse Labs RVA table or roaming the exhibits! Alfie Health can support you in deploying virtual obesity management solutions to maximize your patients outcomes, while increasing practice revenue. We're in network with major Virginia plans including Aetna, BCBS, Medicare and others.
-
-
In the ever-evolving landscape of healthcare, understanding patient access to specialized care is paramount. As part of our commitment to fostering meaningful discussions and solutions in this realm, we're proud to share that our COO, Rohit Rustagi, will be presenting his insights at the 2023 World Obesity Conference in Boston, MA this coming week! Rohit's talk will delve into the intricacies of regional disparities in obesity care access, focusing on wait times across top U.S. hospitals. This topic is not just about numbers, but about real people waiting for essential medical attention. Our goal is to: 1) Help audiences grasp the current barriers patients face when seeking obesity treatment, 2) Explore innovative strategies to enhance patient access and reduce wait times, and 3) Contemplate on the urgent necessity for a broader understanding and approach to obesity medicine and the role of health systems in addressing it. 🔗 Link to the abstract in comments!
-
-
Episode 6 of Beyond BMI went live this morning! In today's episode, we cover the rise of obesity in certain states, discuss research around early intervention in childhood obesity, highlight the rise in ABOM certification registrations in the past year, investigate the interplay between obesity and sleep, and take a look at the connection between obesity and severe knee pain. 🎧 Listen here: https://lnkd.in/dXpD6EMY
Episode 6: September 25, 2023
https://spotify.com
-
Episode 4 of Beyond BMI out today! In this episode we: 🚬 Dive into new research from The University of Kansas around big tobacco's unexpected role in creating hyper-palatable foods that lead to food addictions and overconsumption, 💉 Share a report from Morgan Stanley on the potential ripple effects anti-obesity medications have on the food industry and consumption habits, 🫀 Cover research from the Mamas Mamas's team at Keele University which highlights a three-fold increase in cardiovascular death since 1999, disproportionately affecting black individuals, 🇬🇧 Discuss the approval and distribution of Wegovy in the UK, and how potential affordability is affected by shortages of the medication, and 🧪 Highlight new research from Vanderbilt University Medical Center around new ways to treat obesity-causing metabolic pathways. 🎧 Listen here: https://lnkd.in/eJh5QHeG
Episode 4: September 11, 2023
https://spotify.com
-
Episode 3 of Beyond BMI was published this morning! In this episode we: 🗽 Explore differences in access and utilization of new weight loss medications and how that correlates with neighborhood wealthiness in New York as reported by The New York Times, 💰 Cover the high cost of preventing a single cardiovascular event using semaglutide, as analyzed by Airfinity Ltd, following-up with the recent reports from the SELECT trial on the effectiveness of Wegovy in preventing CVD (sneak peak, it's $1.1M), ⚖️ Reconsider the use of BMI as a standard for obesity measurement, given that BMI misclassifies youth with body fat % that would indicate they have obesity, 😋 Talk about a new drug in Phase I trials that may reduce obesity without affecting patient's underlying appetite, as investigated by the Institute for basic science (IBS), and 🧠 and, present new research from the University of Pennsylvania Perelman School of Medicine highlighting newly discovered links between brain chemistry and appetite. If you like this episode, please rate and review it! 🎧 Listen here: https://lnkd.in/eZCrtQFX
Episode 3: September 5, 2023
https://spotify.com